Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

VRTX
Vertex Pharmaceuticals IncorporatedUS flagNASDAQ Global Select
482.00
USD
+1.50
- -
122.33BMarket Cap

Vertex Pharmaceuticals Incorporated (VRTX) Stock Split History

Learn about Vertex Pharmaceuticals Incorporated's most recent 2-for-1 basis stock split on August 24, 2000. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Vertex Pharmaceuticals Incorporated's most recent stock split

Split Date: 2000-08-24
Split Ratio: 2:1
Price Before Split: $156.75
Price After Split: $78.38

Developer API

Get VRTX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/VRTX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.00 times more shares (a 2:1 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Vertex Pharmaceuticals Incorporated's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2000-08-242:1No$156.75$78.38

About Vertex Pharmaceuticals Incorporated

Company overview and industry information

Vertex Pharmaceuticals Incorporated (VRTX) operates in the Biotechnology industry. The recent 2-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Vertex Pharmaceuticals Incorporated Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.